CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate
  • Colorectal cancer awareness month

    Fighting Colorectal Cancer with Immunotherapy: What You Need to Know

    While colorectal cancer (CRC) is the third most diagnosed cancer and the third leading cause of cancer…
    March 27, 2025| Ajit Muley, PhD
  • Five Things You Need to Know for National Cancer Prevention Month

    February is National Cancer Prevention Awareness Month, a time to reflect on the steps we can take…
    January 31, 2025| Ajit Muley, PhD
  • Introducing CRI’s IO Insights: Your Monthly Guide to the Latest in Immunotherapy

    For over 70 years, the Cancer Research Institute (CRI) has been a leader in the fight against…
    December 19, 2024| Ajit Muley, PhD
  • CICON24 Recap: Key Breakthroughs and Bold Conversations Shaping the Future of Immunotherapy

    The Cancer Immunotherapy Conference (CICON24) opened with a palpable sense of urgency and optimism, bringing together the…
    September 17, 2024| Ajit Muley, PhD
  • 5 Things to Know if You Missed CICON24

    CICON24 wrapped up on September 11, 2024, at the Gaylord National Resort and Convention Center in National…
    September 13, 2024| Ajit Muley, PhD
  • Supercharging T Cells to Fight Cancer: A Revolutionary Discovery

    In the battle against cancer, our immune system’s T cells are frontline soldiers, designed to seek out…
    September 13, 2024| Ajit Muley, PhD
  • CICON24 Day 4 Recap: Pioneering Cellular Therapies and Cancer Vaccines Shape the Future of Cancer Treatment

    Led by inaugural CRI Lloyd J. Old STAR, Yvonne Chen, PhD, from UCLA, day four of CICON24…
    September 11, 2024| Ajit Muley, PhD
  • CICON24 Day 3 Recap: Advances in T Cell Tolerance, Metabolism, and the Microbiome in Cancer Immunotherapy

    Day three of CICON24 continued the momentum of the previous days with an impressive lineup of talks…
    September 10, 2024| Ajit Muley, PhD
  • CICON24 Day 2 Recap: Exploring Cancer Vaccines, Immune Health, and Future Therapies 

    NATIONAL HARBOR —Day two of CICON24 began with an impactful keynote by Cathy Wu, MD, from Dana…
    September 9, 2024| Ajit Muley, PhD

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute